Duo Liu | Epidemiology | Best Researcher Award

Published on by Health Scientists

Prof. Duo Liu | Epidemiology | Best Researcher Award 

Deputy Director, Department of Clinical Pharmacy | Harbin Medical University | China

Professor Duo Liu, Chief Pharmacist and Doctoral Supervisor at Harbin Medical University Cancer Hospital, is a distinguished pharmaceutical scientist whose research has significantly advanced the fields of pharmacogenomics, pharmacoepidemiology, and precision oncology. With a strong background in medical genetics and pharmacology, Professor Liu has developed a research portfolio that bridges molecular pharmacology with clinical translation, focusing on the genetic mechanisms underlying cancer susceptibility, therapeutic response, and drug resistance. His pioneering contributions include transcriptome-wide association studies identifying novel genetic determinants of pancreatic and prostate cancer risk, as well as investigations into the role of NADPH oxidase polymorphisms and oxidative stress in tumor biology and treatment outcomes. Professor Liu’s scholarly work, published in leading international journals such as Cancer Research, Carcinogenesis, and International Journal of Cancer, has garnered wide recognition for its methodological rigor and clinical relevance. He has successfully led multiple national and institutional research grants, including projects supported by the National Natural Science Foundation of China, and has been honored with several prestigious distinctions for excellence in pharmaceutical sciences and young investigator achievements. As an active member of numerous professional societies, including the Chinese Pharmacological Society and the Anti-Cancer Association of China, Professor Liu contributes to shaping the evolving landscape of cancer pharmacotherapy and drug epidemiology. His collaborations with global research institutions, notably the University of Hawaii Cancer Center, underscore his commitment to advancing international scientific exchange and translational medicine. Through his leadership in clinical pharmacy and mentorship of emerging scientists, Professor Liu continues to drive innovation in personalized cancer treatment and rational drug use, promoting evidence-based healthcare practices that enhance patient outcomes and public health impact worldwide.

Profile: ORCID 

Featured Publications

1. Chen, C., Dong, Q., Wang, H., Dong, S., Wang, S., Lin, W., Jia, C., Dong, M., Jin, Y., & Liu, D. (2025, January 8). The association between NADPH oxidase (NOX) polymorphisms with immunohistochemistry and survival in diffuse large B cell lymphoma patients. Annals of Hematology.

2. Wang, S. F., Dong, S. Q., Dong, Q., Lin, W. X., Dong, M., & Liu, D. (2024). Natural product-induced oxidative stress-synergistic anti-tumor effects of chemotherapeutic agents. Traditional Medicine Research.

3. Dong, S., Chen, C., Di, C., Wang, S., Dong, Q., Lin, W., & Liu, D. (2024, December). The association between NADPH oxidase 2 (NOX2) and drug resistance in cancer. Current Cancer Drug Targets.

4. Liu, D., Bae, Y. E., Zhu, J., Zhang, Z., Sun, Y., Deng, Y., Wu, C., & Wu, L. (2023, December 15). Splicing transcriptome-wide association study to identify splicing events for pancreatic cancer risk. Carcinogenesis.

5. Liu, D., Zhao, T., Zhu, J., Sharapov, S., Tiys, E., & Wu, L. (2023, December 4). Associations between genetically predicted plasma N-glycans and pancreatic cancer risk. All Life.

Foad Kazemi | Biostatistics | Best Researcher Award

Published on by Health Scientists

Dr. Foad Kazemi | Biostatistics | Best Researcher Award

Postdoctoral Fellow at Johns Hopkins University, United States

Dr. Foad Kazemi is a highly accomplished neurosurgeon and researcher with an extensive record of impactful contributions in pediatric traumatic brain injury, neurosurgical outcomes, brain tumors, and the integration of public health and socioeconomic factors into clinical research. His work stands out for developing precision risk assessment models, predictive calculators, and patient-centered quality of life tools that translate directly into improved care. With numerous publications in leading journals, he has demonstrated both productivity and scientific depth while fostering collaborations across multiple disciplines. His innovative use of geospatial analysis, hospital frailty scores, and artificial intelligence further highlights his forward-thinking approach to advancing neurosurgery. While increased senior authorship, global visibility, and mentorship could further strengthen his profile, his achievements already reflect significant clinical relevance and societal impact. Dr. Kazemi’s body of work positions him as a strong candidate for the Best Researcher Award, deserving recognition for his contributions to science and patient care.

Professional Profile

Scopus Profile

Education

Dr. Foad Kazemi’s educational background reflects a strong foundation in medicine and neurosurgery, complemented by continuous academic development through research and scholarly contributions. As a board-certified neurosurgeon, his training has combined rigorous clinical practice with an emphasis on advancing evidence-based care in complex neurological conditions. His education has been shaped not only by formal medical and surgical training but also by an active pursuit of knowledge in fields intersecting with neurosurgery, including public health, artificial intelligence, and socioeconomic determinants of health. This multidisciplinary approach has allowed him to integrate advanced statistical modeling, geospatial analysis, and precision medicine tools into his research, elevating his clinical insights to broader scientific and societal applications. His educational journey reflects both depth and versatility, fostering the expertise necessary to lead innovative research and contribute significantly to improving patient outcomes, while also building bridges between clinical medicine, technology, and population health.

Experience

Dr. Foad Kazemi’s professional experience reflects a distinguished career as a neurosurgeon and researcher with a focus on advancing patient care through innovation and evidence-based practice. As a board-certified neurosurgeon, he has gained extensive clinical expertise in managing complex neurosurgical conditions, particularly pediatric traumatic brain injury, brain tumors, and skull base surgery. Alongside his clinical practice, he has built a strong academic and research portfolio, contributing numerous publications in high-impact journals that address not only surgical outcomes but also broader public health challenges, including socioeconomic disparities and quality of life measures. His professional work demonstrates a unique integration of clinical skills with research excellence, emphasizing predictive modeling, precision risk assessment, and the use of artificial intelligence in neurosurgery. Through multidisciplinary collaborations, he has established himself as a leader in translational research, ensuring that scientific findings are directly applicable to clinical care and policy, ultimately enhancing patient outcomes and healthcare delivery.

Research Interest

Dr. Foad Kazemi’s research interests lie at the intersection of neurosurgery, public health, and translational medicine, with a strong emphasis on improving outcomes for patients with neurological disorders. His primary focus is on pediatric traumatic brain injury, where he explores risk stratification models, predictive scoring systems, and geospatial analyses to identify disparities and optimize care. He is also deeply engaged in studying brain tumors, glioblastoma, and skull base conditions, developing precision risk assessment tools, online calculators, and quality of life instruments that translate research into practical clinical applications. In addition, he is interested in the integration of artificial intelligence, machine learning, and advanced imaging techniques to enhance diagnostic accuracy and personalize treatment strategies. His work frequently incorporates socioeconomic and demographic factors, reflecting a commitment to addressing health inequities within neurosurgery. Through these diverse research pursuits, Dr. Kazemi seeks to advance patient-centered, high-value care while contributing innovative solutions to global neurosurgical challenges.

Award and Honor

Dr. Foad Kazemi has earned recognition through his extensive contributions to neurosurgery and clinical research, reflected in multiple publications in leading international journals and collaborations with prominent researchers worldwide. His board certification as a neurosurgeon itself stands as a professional honor, signifying his expertise and commitment to the highest standards of clinical care. His work on pediatric traumatic brain injury, brain tumors, and risk prediction models has positioned him as a respected voice in both clinical and academic communities. While much of his recognition has come in the form of peer-reviewed publications and acceptance into highly regarded journals, his contributions also extend to the development of innovative tools such as predictive models and patient-centered quality of life instruments, which further highlight his role as a pioneer in translational neurosurgery. These achievements represent professional honors that underscore his dedication to advancing science, improving outcomes, and setting new standards in neurosurgical research.

Research Skill

Dr. Foad Kazemi possesses a diverse and advanced set of research skills that bridge clinical neurosurgery with innovative scientific methodologies. He is highly skilled in designing and conducting clinical studies, with expertise in pediatric traumatic brain injury, brain tumors, and neurosurgical outcomes. His proficiency extends to advanced statistical analysis, predictive modeling, and Bayesian time series approaches, which he applies to develop risk assessment tools and outcome calculators that directly benefit patient care. He has strong capabilities in utilizing artificial intelligence and machine learning for medical imaging, brain tumor classification, and health data analytics, demonstrating his ability to integrate technology with clinical practice. Additionally, his research incorporates geospatial and socioeconomic analyses, reflecting a commitment to addressing health inequities. Dr. Kazemi’s ability to collaborate across multidisciplinary teams, translate complex data into clinical applications, and publish in high-impact journals underscores his strong analytical, technical, and translational research skills.

Publications Top Notes

Title: Exploring perspectives on skull base chordoma management: a modified Delphi approach to consensus
Authors: Saket Myneni, A. Karim Ahmed, Foad Kazemi, Saraswathula A., Zwagerman N. T., Su S. Y., Choby G., Wang E. W., Van Gompel J. J., Redmond K. J., McKean E. L., Snyderman C. H., Gardner P. A., Rowan N. R., Mukherjee D

Title: Timing of pharmacological venous thromboembolism prophylaxis after firearm-related penetrating brain injury
Authors: Jiaqi Liu, Tej D. Azad, Foad Kazemi, Kathleen Renee Ran, Megan Parker, Vikas Vattipally, Carlos Aguilera, Wuyang Yang, Caitlin Hicks, Elliot Haut, Christopher D. Witiw, Debraj Raj Mukherjee, James Byrne

Title: Adverse outcomes in child abuse: a 7-year analysis of patients with traumatic brain injury
Authors: Foad Kazemi, Kai Jiang, Sarah Robinson, Alan R. Cohen

Title: Pediatric traumatic brain injury: precision risk assessment models and an online calculator for enhanced patient care
Authors: Foad Kazemi, Elena Ghotbi, Julian L. Gendreau, Alan R. Cohen

Conclusion

Overall, Dr. Kazemi is a strong candidate for the Best Researcher Award given his extensive publication record, multidisciplinary research approach, and commitment to improving neurosurgical outcomes through innovative methods. His work shows clear clinical relevance, societal importance, and scientific rigor. With continued emphasis on leadership roles in authorship, broader international visibility, and sustained mentorship contributions, his profile would align even more strongly with the qualities sought in outstanding researchers. Based on his current achievements, he is well-suited for recognition through this award.